Quest Diagnostics Inc (DGX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access DGX Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Quest Diagnostics Inc's cash-generating activities.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income1,168.00
Depreciation & amortization293.00
Amortization of Other Assets75.00
Extraordinary loss0.00
Restructuring charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Acquisition of in process R & D0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation43.00
Minority interests14.00
Tax benefit on stock options0.00
Provision For Special Charges-
Gainon Sale of Royalty Rights-
Accounts Receivable-
Gain Loss On Disposition Of Joint Venture-
Contract With Customer Asset Credit Loss Expense1.00
Income taxes0.00
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable259.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities130.00
Accrued restructuring costs0.00
Deferred income0.00
Prepaid expenses0.00
Other Working Capital-3.00
Other Noncash Income (Expense)-14.00
Other net26.00
Payments for (Proceeds from) Other Operating Activities-1,116.00
Discontinued operations0.00
Net Cash flow from Operating Activities875.00
Investing Activities
Capital Expenditures-252.00
Sale of Capital Items0.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Proceeds from other investments0.00
Proceeds from Divestiture of Royalty Rights-
Decrease in Restricted Cash0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Purchases of Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-38.00
Proceeds from Sale of Equity Method Investments0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Note receivable0.00
Payments for (Proceeds from) Other Investing Activities4.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-286.00
Financing Activities
Short-term debt Net-110.00
Other borrowing transactions0.00
Long-term debt - borrowings-7.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-21.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net-147.00
Other net110.00
Proceeds From Borrowings-
Paymentofdeferredbusinessacquisitionconsideration-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents420.00
Payments of Ordinary Dividends, Noncontrolling Interest-22.00
Dividends paid-184.00
Net Cash Flow from Financing Activities-381.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow623.00
Total Cash Flow206.00
4 historic quarters locked

Sign in to unlock the full Quest Diagnostics Inc cash flow history.

About Quest Diagnostics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 23, 2026
  • Source: dgx-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001022079-26-000070

Figures are derived from filed reports and may be restated. Historical data is subject to revision.